OBJECTIVES: The primary focus of manufacturers’ reimbursement submissions in Germany is on demonstrating the added benefit of a product versus the appropriate comparator(s). Some decisions made by Gemeinsamer Bundesausschuss (G-BA) result in a time-limited approval, after which there should be a review.  This study analyses any completed reviews conducted by the G-BA.  METHODS: G-BA decisions were searched to identify restricted decisions and subsequent reviews. Data were extracted, the reasons for the restrictions and the ways these were addressed in the reviews, were analysed.  RESULTS: CONCLUSIONS: The results indicate that restricted decisions provide manufacturers with the opportunity to collect additional data and improve the final added benefit recommendation. If manufacturers address the G-BA’s criticism of the original submission, more favourable added benefit levels can be achieved during the review. Furthermore, it shows that EMA decisions influence G-BA decision making.